维普中文期刊产品整合服务
27篇 您的检索式:作者名="Heemstra KA"
    题名 作者 年代 出处 被引量
1Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma显示文摘Heemstra KA Liu Y: Stokkel M 2007Clin Endocrinol (Oxf)2007,66,1:1
2Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma显示文摘Heemstra KA van der Deure WM Peeters RP 2008Eur J Endocrinol2008,159,:1
3Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts 显示文摘Visser WE Heemstra KA Swagemakers SM 2009J Clin Endocrinol Metab2009,94,9:1
4Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay显示文摘Hovens GC Heemstra KA Buiting AM 2007Nuel Med Commun2007,28,2:1
5Serum thyroglobulin concentrations predict disease-free remission and death indifferentiated thyroid carcinoma显示文摘Heemstra KA Liu YY Stokkel M 2007Clin Endocrinol(Oxf)2007,66,:1
6The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothal- amus-pituitary-thyroid axis in patients treated for dif- ferentiated thyroid carcinoma 显示文摘Hoftijzer HC Heemstra KA Visser TJ 2011J C/in Endocrinol Metab2011,96,9:1
7Rituximab in relaps- ing Graves' disease, a phase II study显示文摘Heemstra KA Toes RE Sepers J 2008Eur J Endocrinol2008,159,5:1
8Serum thyroglobulin con- centrations predict disease-free remission and death in differentiated thyroid carcinoma 显示文摘Heemstra KA Liu YY Stokkel M 2007Clin Endocrinol ( Oxf)2007,66,1:1
9Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or pa- tients with Hashimoto thyroiditis显示文摘Heemstra KA Hoftijzer HC van der Deure WM 2009Clin Endocrinol2009,71,2:1
10Rituximab in relapsing Graves' disease,a phase Ⅰ study显示文摘Heemstra KA Toes RE Sepers J 0,,:1
11Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial显示文摘Heemstra KA Smit JW Eustatia-Rutten CF 2006Clin Endocrinol (Oxf)2006,65,6:1
12Serum thyroglob- ulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma 显示文摘Heemstra KA Liu YY Stokkelt M 2006Clin En- docrinol (Oxt)2006,2007,66:1
13Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma 显示文摘Hoftijzer H Heemstra KA Morreau H 2009Eur J Endocri- nol2009,161,6:1
14Quality of life in cured patients with differentiated thyroid carcinoma显示文摘Hoftijzer HC Heemstra KA Corssmit EP 2008J Clin En- docrinol Metab2008,93,1:1
15The effects of thyrotropin-suppressive therapy on bone metabolism in pa tients with well-differentiated thyroid carcinoma 显示文摘Heemstra KA Hamdy NA Romijn JA 2006Thyroid2006,16,6:1
16Rituximab in relap- sing Graves' disease, a phase II study 显示文摘Heemstra KA Toes RE Sepers J 2008Eur J Endocri- nol2008,159,:1
17The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma显示文摘Heemstra KA Hamdy NA Romijn JA 2006Thyroid2006,16,6:1
18Beneficial effects of sorafenib on tumor progression, but not on radioiodine up- take, in patients with differentiated thyroid earcinoma显示文摘Hoftijzer H Heemstra KA Morreau H 2009Eur J Endo2009,161,6:1
19Quality of life in cured patients with differentiated thyroid carcinoma 显示文摘Hoflijzer HC Heemstra KA Corssmit EP 2008J Clin Endocrinol Metab2008,93,1:1
20The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma 显示文摘Heemstra KA Hamdy NA Romijn JA 2006Thyroid2006,16,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费